MSB 4.89% $1.07 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-247

  1. 15,491 Posts.
    lightbulb Created with Sketch. 5577
    Great post @The Yankee .... I nominate @ecoool2 @otherperspective @Treed @benelong @stanjupiter @Anjo-Roch @vinn @antibody @Cr4sac @stokdog @dolcevita just for starters ..... I will put something together over the weekend, but can I please ask if anyone does submit something that it is professional in nature; has had both the grammar and spelling checked etc etc ..... the last thing IMO Mesoblast needs is a lot of half baked submissions - please don’t take offence to these comments and take it in the context it is meant .... we are on the international stage now - just sayin’

    There have been some really well researched posts on here by the people I have mentioned over the years with some real science links and references in support of their information .... some of you have medical and/or scientific backgrounds and these are the types of comments I would like to see in support of Ryoncil ....

    Enjoy the weekend MSB’ers
    Last edited by col69: 08/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.